Image

Development of a Battery of Audiological Tests for the Precision Diagnosis of Age-related Hearing Loss

Development of a Battery of Audiological Tests for the Precision Diagnosis of Age-related Hearing Loss

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Age-related hearing loss, or presbycusis, is caused by many genetic and environmental factors. Its prevalence poses a public health challenge of early identification and effective hearing aid treatment. However, the lack of screening and of a validated audiological test battery to diagnose an individual's needs and to guide hearing aid adjustments is a major obstacle.

Furthermore, monogenic forms of hearing loss affect only one functional module of hearing. The audiological test(s) dependent on the function of this module are affected, in a progressive manner, but not the others. A previous study showed that in early onset presbycusis patients, a quarter of the subjects tested were affected by monogenic presbycusis.

The collection of audiological and vestibular tests, carried out on proven monogenic presbycusis patients and compared to that of normal hearing patients, would constitute a battery of tests allowing a precision diagnosis, then developed to all forms of presbycusis in order to study if the identification of abnormal functional modules can usefully guide the diagnosis and the early fitting.

Description

The AUDIOGENAGE project is a multi-center, non-invasive case-control study conducted by CERIAH (CEntre de Recherche et d'Innovation en Human Audiology) and LCA (Laboratory de correction auditive) in 700 volunteer participants identified in two groups:

  • 500 Patients with age-related hearing loss of anticipated onset,
  • 200 Control subjects, considered as normal hearing for their age at inclusion.

All participants will undergo 6h audiological and vestibular tests, and also neurocognitive test (self-questionnaire). These tests will be conducted over 2 to 4 visits. A 10 mL-blood sample will be collected for a genetic analysis.

Eligibility

Inclusion Criteria:

For all participants:

  • Be over the age of 18,
  • Be affiliated to a social security system,
  • Have a good command of the French language (oral and written).

For the group of participants with anticipated presbycusis:

  • Over the age of 40, having a hearing aid recipient or coming for a first hearing aid recipient
  • Between 18 and 40, having a hearing aid recipient, coming for a first hearing aid recipient or declare a progressive genetic birth defect

For healthy volunteers:

  • Have no known hearing loss.

Exclusion Criteria:

  • Report having been chronically exposed to loud sounds.
  • Have a history of ototoxic substances,
  • To have sequelae of ear infections and/or a history of ENT disease that permanently affects hearing or balance,
  • Have an ethnic origin for which the Pasteur Institute does not have information on the frequency of variants of the genes studied.
  • Have type II diabetes,
  • Have a neurological or psychiatric condition that interferes with comprehension or ability to move,
  • Be under guardianship,
  • Be deprived of liberty by judicial or administrative decision, or be subject to legal protection,
  • Not being subject to a social security system,
  • Taking narcotic substances, alcohol or medication that diminishes cognitive abilities.

Study details
    Presbyacusis

NCT05312983

Institut Pasteur

21 March 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.